CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
No intervention: We are testing for the presence of allodyniaother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00329771
NCT00329771N/ACompleted
CompareCT.gov

Brush Allodynia in Patients With Episodic Migraine During an Acute Attack.

Thomas Jefferson University·observational·Posted May 25, 2006·Updated Mar 27, 2024

In Brief

An observational study evaluating No intervention: We are testing for the presence of allodynia for Migraine. Completed, enrolled 28 participants across 1 site.

Detailed Summary

Cutaneous allodynia (pronounced q-tane-ee-us all-o-din-ee-a) is common in migraine. It is a heightened skin sensitivity during an active migraine attack. Migraine attacks in patients who experience allodynia are more difficult to treat. This study intends to collect and evaluate data on the phenomenon of allodynia in patients with episodic migraine during an actual attack. The results of this study may help clinicians better understand allodynia, thereby helping them diagnose and more effectively manage patients with migraine and allodynia.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 25, 2006
Enrollment StartMar 1, 2006
Primary CompletionDec 1, 2006
Study CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 20.1 years ago

Interventions

No intervention: We are testing for the presence of allodyniaother

We are testing for the presence of abnormal sensation (allodynia) during a migraine attack.